EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanisms of Action of Ribavirin in Antiviral Therapies

R C Tam, J Y Lau, Z Hong

Antiviral Chemistry and Chemotherapy · 2001-10 · 12 (5) · 261-272

DOI: 10.1177/095632020101200501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antiviral Chemistry and Chemotherapy, online erschienen am 01.10.2001. Verfasst von R C Tam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, ICN Pharmaceuticals, Costa Mesa, Calif, USA. rtam@icnpharm.com. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although ribavirin was originally synthesized over 30 years ago and has been used to treat viral infections as monotherapy (respiratory syncytial virus and Lassa fever virus) or with interferon-α (IFN-α) as combination therapy (hepatitis C virus), the precise mechanism of its therapeutic activities remains controversial. In this review we focus on two main biological properties of ribavirin: its indirect and direct antiviral activities (with particular emphasis on its efficacy against chronic hepatitis C infection). Each property could individually or collectively account for its clinical efficacy against viral infections. First, with emphasis on the evidence for indirect activities of ribavirin, we will review the clinical observations that suggest that the immunomodulatory properties of ribavirin can in part account for its antiviral activities in vivo. We will then describe the mode of ribavirin's direct antiviral activities. These direct activities can be ascribed to several possible mechanisms, including the recently described activity as an RNA mutagen, a property that may be important in driving a rapidly mutating RNA virus over the threshold to ‘error catastrophe′.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntiviral AgentsDrug Therapy, CombinationHepatitis C, ChronicHumansMutagenesisRNA VirusesRibavirinT-LymphocytesVirus Replication

Substanzen

Antiviral AgentsRibavirin

Autor:innen und Institutionen

  • Research and Development, ICN Pharmaceuticals, Costa Mesa, Calif, USA. rtam@icnpharm.com

Zitieren

APA

Tam, R. C., Lau, J. Y., & Hong, Z. (2001). Mechanisms of Action of Ribavirin in Antiviral Therapies. Antiviral Chemistry and Chemotherapy, 12(5), 261-272. https://doi.org/10.1177/095632020101200501

Vancouver

Tam RC, Lau JY, Hong Z. Mechanisms of Action of Ribavirin in Antiviral Therapies. Antiviral Chemistry and Chemotherapy. 2001;12(5):261-272. doi:10.1177/095632020101200501

BibTeX
@article{Tam2001,
  author = {Tam, R C and Lau, J Y and Hong, Z},
  title = {Mechanisms of Action of Ribavirin in Antiviral Therapies},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2001},
  volume = {12},
  number = {5},
  pages = {261--272},
  doi = {10.1177/095632020101200501}
}
Kostenlos starten →